Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guerin

被引:27
作者
Hamerman, JA
Aderem, A
机构
[1] Inst Syst Biol, Seattle, WA 98105 USA
[2] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.167.4.2227
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophage activation during the immune response to intracellular bacteria is critical for resolution of the infection. We have investigated the pathway of macrophage activation during murine Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection. Three distinct phenotypes of macrophages were identified and compared: resident peritoneal macrophages, day 2 postinfection macrophages, and 12-day postinfection macrophages. Compared with resident peritoneal macrophages, day 2 BCG macrophages expressed intermediate levels of the cell surface receptors Mac1 and F4/80 and low levels of MHC class II molecules. These cells were highly phagocytic and produced large amounts of mRNA encoding the chemokine IP-10. In addition, day 2 BCG macrophages did not generate reactive nitrogen intermediates, though they were primed to do so, and did not have increased levels of TNF-alpha mRNA. Blockade of monocyte influx into the peritoneal cavity using Abs to platelet endothelial cell adhesion molecule I had no effect on the appearance of day 2 BCG macrophages, suggesting this cell can differentiate from resident peritoneal macrophages. In contrast to day 2 BCG macrophages, day 12 BCG macrophages were poorly phagocytic, but produced high levels of reactive nitrogen intermediates, IP-10 and TNF-alpha mRNA, and class II MHC molecules. We propose that day 2 BCG macrophages are specialized for phagocytic uptake of pathogens from the extracellular space, whereas day 12 BCG macrophages are specialized for killing of the internalized pathogens. This functional transition during activation is reminiscent of that seen during maturation/activation of the related dendritic cell lineage induced by bacterial or inflammatory stimuli.
引用
收藏
页码:2227 / 2233
页数:7
相关论文
共 50 条
  • [41] In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates
    Geisel, RE
    Sakamoto, K
    Russell, DG
    Rhoades, ER
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (08) : 5007 - 5015
  • [42] Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo
    Luo, Y.
    Chen, X.
    O'Donnell, M. A.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (02) : 370 - 378
  • [43] EFFECT OF MYCOBACTERIUM-BOVIS (BACILLUS CALMETTE-GUERIN) ON MACROPHAGE RANDOM MIGRATION, CHEMOTAXIS, AND PINOCYTOSIS
    POPLACK, DG
    SHER, NA
    CHAPARAS, SD
    BLAESE, RM
    [J]. CANCER RESEARCH, 1976, 36 (04) : 1233 - 1237
  • [44] Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination
    Ota, MOC
    Vekemans, J
    Schlegel-Haueter, SE
    Fielding, K
    Sanneh, M
    Kidd, M
    Newport, MJ
    Aaby, P
    Whittle, H
    Lambert, PH
    McAdam, KPWJ
    Siegrist, CA
    Marchant, A
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (02) : 919 - 925
  • [45] Triacylglycerol Utilization Is Required for Regrowth of In Vitro Hypoxic Nonreplicating Mycobacterium bovis Bacillus Calmette-Guerin
    Low, Kai Leng
    Rao, P. S. Srinivasa
    Shui, Guanghou
    Bendt, Anne K.
    Pethe, Kevin
    Dick, Thomas
    Wenk, Markus R.
    [J]. JOURNAL OF BACTERIOLOGY, 2009, 191 (16) : 5037 - 5043
  • [46] Multiple mycotic aneurysms due to Mycobacterium bovis after intravesical bacillus Calmette-Guerin therapy
    Coscas, Raphael
    Arlet, Jean-Benoit
    Belhomme, Denis
    Fabiani, Jean-Noel
    Pouchot, Jacques
    [J]. JOURNAL OF VASCULAR SURGERY, 2009, 50 (05) : 1185 - 1190
  • [47] A Novel Monoclonal Antibody Against A60 Antigen of Mycobacterium bovis Bacillus Calmette-Guerin
    Bakhtiyari, Salar
    Haghani, Karimeh
    Farhadi, Elham
    Soukhtanloo, Mohammad
    Rezaei, Nima
    Taghikhani, Mohammad
    [J]. HYBRIDOMA, 2010, 29 (03): : 211 - 215
  • [48] Phenotypic and Genotypic Drug Susceptibility Assessment of Mycobacterium bovis Bacillus Calmette-Guerin Clinical Strains
    Sisco, Maria Carolina
    da Silva, Marlei Gomes
    de Carvalho, Luciana Distasio
    Dias Campos, Carlos Eduardo
    De Souza Caldas, Paulo Cesar
    Lopez, Beatriz
    Arguelles, Claudia
    Carvalho, Ana Carolina
    de Waard, Jacobus
    Suffys, Philip
    Duarte, Rafael Silva
    [J]. INFECTION AND DRUG RESISTANCE, 2021, 14 : 459 - 466
  • [49] Growth inhibition of HeLa cell by internalization of Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Tokyo
    Kitamura, Akira
    Mastumoto, Sohkichi
    Asahina, Izumi
    [J]. CANCER CELL INTERNATIONAL, 2009, 9
  • [50] Late Onset Disseminated Mycobacterium bovis in a Patient After Bacillus Calmette-Guerin (BCG) Immunotherapy
    Short, Jack
    Sakata, Kenneth
    Vikram, Holenarasipur
    Kelemen, Katalin
    Swanson, Karen
    [J]. CHEST, 2015, 148 (04)